𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn

✍ Scribed by Mete Akisu; Mehmet Yalaz; Sertac Arslanoglu; Nilgun Kultursay


Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
130 KB
Volume
26
Category
Article
ISSN
0344-5607

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Characterization of indium-111 labeled r
✍ D. J. Hnatowich; F. Virzi; P. W. Doherty; J. Wilson; J. Rosa; J. E. Ansell πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 708 KB

The in vitro functional properties of recombinant tissue plasminogen activator (rt-PA), its biodistribution in mice, and its pharmacokinetics and clot localization properties in dogs have been investigated after labeling rt-PA with 111In. The rt-PA was coupled with the bicyclic anhydride of DTPA usi

Intravesical recombinant tissue plasmino
✍ William A. See πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 941 KB

The mechanism by which intravesical recombinant tissue plasminogen activator (rTPA) prevents tumor cell adherence to injured bladder surfaces, and the optimal parameters for the in vivo use of rTPA for adherence prevention, were evaluated. Intravesical rTPA decreased tumor cell adherence to sites of

Pharmacokinetics and pharmacodynamics of
✍ Stephen Eppler; Taurence Senn; Ellen Gilkerson; Nishit B. Modi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 1 views

Recombinant tissue-type plasminogen activator (rt-PA) is indicated for the treatment of acute myocardial infarction as a dose of up to 100 mg. Several clinical trials have suggested that higher patency rates can be achieved with a rapid drug administration. A study was conducted in rabbits to determ